Biotie Therapies is a specialized drug development company engaged in the development of drugs to address diseases of high unmet medical need and significant market potential, including neurodegenerative and psychiatric disorders and inflammatory and fibrotic liver disease. The company’s development portfolio is strong and balanced, with several innovative small molecule and biological drug candidates at various stages of clinical development.  For more information, visit the company’s Web site at www.biotie.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: